Form 4: Eli Lilly Director Acquires Shares Through Deferred Compensation Plan

Eli Lilly & Co. Director Gabrielle Sulzberger acquired 6.14 shares of common stock at a price of $807.58 per share, as part of the company's Directors' Deferral Plan.

Summary

• Eli Lilly & Co. (LLY) Director Gabrielle Sulzberger acquired 6.14 shares of common stock on June 16, 2025.
• The acquisition price per share was $807.58.
• These shares were acquired as stock units under the Lilly Directors' Deferral Plan, in lieu of cash compensation.
• The acquired stock units will be settled in shares of common stock following Ms. Sulzberger's separation from service.
• Following this transaction, Ms. Sulzberger beneficially owns a total of 2,579.55 shares of Eli Lilly common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as a director's acquisition of shares, even through a deferred compensation plan, generally signals confidence in the company's future and aligns their interests with shareholders. It is a routine, expected transaction.

Positives

• The acquisition of shares by a director, even through a deferred compensation plan, indicates continued alignment of management interests with shareholder interests.
• The transaction was conducted under a Rule 10b5-1 plan, demonstrating a pre-arranged and compliant approach to insider transactions.

Future Outlook

The document indicates that the acquired stock units will be settled in shares of common stock following the reporting person's separation from service, which is a future event contingent on the director's tenure.

Management Comments

• The shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

This Form 4 filing represents a routine insider transaction, common across all industries, where a director receives equity as part of their compensation package. Such transactions are standard practice for aligning the interests of corporate leadership with those of shareholders.

Corporate Governance

Related Party Transactions

• The acquisition of common stock by Director Gabrielle Sulzberger from Eli Lilly & Co. as part of her compensation is a related party transaction.

Stakeholder Impact

• Shareholders: The acquisition of shares by a director can be viewed positively as it aligns the director's financial interests with the long-term performance of the company, potentially signaling confidence.

Next Steps

• Settlement of the acquired stock units into common stock shares upon Gabrielle Sulzberger's separation from service.

Key Dates

Keywords

Eli Lilly, LLY, Form 4, Insider Transaction, Director Compensation, Stock Acquisition, Deferred Compensation, Corporate Governance